Preferred Label : sulfonamides;

MeSH definition : A group of compounds that contain the structure SO2NH2.;

MeSH synonym : Sulfonamide;

Wikipedia automatic translation : Sulfonamide (medicine);

Related MeSH term : sulfonamide mixtures; Mixtures, Sulfonamide; Sulfonamide Mixture; Mixture, Sulfonamide;

Wikipedia link : https://en.wikipedia.org/wiki/Sulfonamide (medicine);

Is substance : O;

Details


Main resources

You can consult :

A group of compounds that contain the structure SO2NH2.

https://ansm.sante.fr/tableau-acces-derogatoire/venclyxto-10-mg-50mg-100-mg-comprimes-pellicules?#
2025
false
false
false
France
French
venetoclax
venetoclax
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
leukemia, myeloid, acute
precursor cell lymphoblastic Leukemia-Lymphoma
Refractory Acute Lymphoblastic Leukemia
Recurrent Acute Lymphoblastic Leukemia
leukemia, lymphocytic, chronic, B-Cell
drug information
Product containing only venetoclax in oral dose form (medicinal product form)
guidelines for drug use
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
Certain sulfonamide diuretics and the risk of choroidal effusion with acute myopia and/or acute angle-closure glaucoma
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/mars-2021.html#a10
2021
false
false
false
Canada
French
English
pharmacovigilance note
diuretics
Sulfonamide diuretic (substance)
Choroidal effusion
myopia
glaucoma, angle-closure
acute disease
choroid diseases
acetazolamide
chlorthalidone
hydrochlorothiazide
indapamide
metolazone
sulfonamides

---
https://www.has-sante.fr/jcms/p_3280978/fr/maviret-vhc-pediatrique
2021
false
false
false
France
glecaprevir and pibrentasvir
administration, oral
insurance, health, reimbursement
treatment outcome
child
hepatitis C, chronic
antiviral agents
evaluation of the transparency committee
glecaprevir
pibrentasvir
benzimidazoles
glecaprevir and pibrentasvir
drug combinations
pyrrolidines
quinoxalines
sulfonamides

---
https://www.ema.europa.eu/en/medicines/human/EPAR/inrebic
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fedratinib
Fedratinib
drug approval
europe
fedratinib
adult
primary myelofibrosis
Myelofibrosis due to and following polycythemia vera (disorder)
Post-Essential Thrombocythemia Myelofibrosis
orphan drug production
administration, oral
Janus Kinase Inhibitors
Janus Kinase Inhibitors
JAK2 Inhibitor
drug monitoring
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Product containing precisely fedratinib (as fedratinib hydrochloride) 100 milligram/1 each conventional release oral capsule (clinical drug)
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
pyrrolidines
sulfonamides
pyrrolidines
sulfonamides

---
2021
false
false
false
France
French
administration, oral
baricitinib
risk management
pregnancy
baricitinib
guidelines for drug use
breast feeding
patients guideline
dermatitis, atopic
arthritis, rheumatoid
baricitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
drug monitoring
deep vein thrombosis
pulmonary embolism
cholesterol, HDL
cholesterol, LDL
Infections
vaccines, attenuated
venous thrombosis
azetidines
sulfonamides
purines
pyrazoles
azetidines
sulfonamides
purines
pyrazoles

---
https://ansm.sante.fr/informations-de-securite/venclyxto-r-v-venetoclax-comprimes-pellicules-recommandations-actualisees-concernant-le-syndrome-de-lyse-tumorale-slt-chez-les-patients-atteints-de-leucemie-lymphoide-chronique
2021
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
venetoclax
tumor lysis syndrome
leukemia, lymphocytic, chronic, B-Cell
venetoclax
antineoplastic agents
administration, oral
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.cadth.ca/fr/fedratinib
2021
false
false
false
Canada
French
drug information
Fedratinib
Inrebic
Product containing only fedratinib in oral dose form (medicinal product form)
pyrrolidines
sulfonamides

---
https://www.has-sante.fr/jcms/p_3237060/fr/olumiant-dermatite-atopique-moderee-a-severe-de-l-adulte
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
baricitinib
adult
dermatitis, atopic
administration, oral
Janus Kinase Inhibitors
baricitinib
evaluation of the transparency committee
azetidines
sulfonamides

---
https://www.has-sante.fr/jcms/p_3284614/fr/venclyxto-venetoclax-leucemie-aigue-myeloide
2021
false
false
false
France
evaluation of the transparency committee
venetoclax
sulfonamides
treatment outcome
insurance, health, reimbursement
administration, oral
venetoclax
leukemia, myeloid, acute
antineoplastic agents
adult
antineoplastic combined chemotherapy protocols
azacitidine
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/jcms/p_3106158/fr/venclyxto
2020
false
false
false
France
venetoclax
drug therapy, combination
Rituximab
adult
leukemia, lymphocytic, chronic, B-Cell
administration, oral
antineoplastic agents
venetoclax
evaluation of the transparency committee
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/jcms/p_3225446/fr/braftovi
2020
false
false
false
France
insurance, health, reimbursement
treatment outcome
encorafenib
encorafenib
administration, oral
adult
BRAF V600E Mutation Present
colorectal neoplasms
colorectal neoplasms
mutation
neoplasm metastasis
Colorectal cancer metastatic
proto-oncogene proteins b-raf
antineoplastic combined chemotherapy protocols
Cetuximab/Encorafenib Regimen
Cetuximab
antineoplastic agents
protein kinase inhibitors
proto-oncogene proteins b-raf
metastatic colorectal cancer with a BRAF V600E mutation
evaluation of the transparency committee
carbamates
sulfonamides

---
https://www.has-sante.fr/jcms/p_3224398/fr/maviret
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
glecaprevir and pibrentasvir
Glecaprevir/Pibrentasvir
glecaprevir
pibrentasvir
antiviral agents
insurance, health, reimbursement
Duration of treatment (qualifier value)
hepatitis C, chronic
glecaprevir
benzimidazoles
quinoxalines
sulfonamides
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
https://www.has-sante.fr/jcms/p_3215874/fr/costec
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
dorzolamide-timolol combination
dorzolamide-timolol combination
timolol, combinations
administration, ophthalmic
glaucoma, open-angle
ocular hypertension
exfoliation syndrome
adrenergic beta-antagonists
carbonic anhydrase inhibitors
evaluation of the transparency committee
sulfonamides
thiophenes
timolol
drug combinations
sulfonamides
thiophenes
timolol
drug combinations

---
https://ansm.sante.fr/tableau-atu-rtu/braftovi-75-mg-gelule
2020
false
false
false
France
French
drug information
encorafenib
encorafenib
administration, oral
Cetuximab
adult
antineoplastic combined chemotherapy protocols
BRAF V600E Mutation Present
neoplasm metastasis
colorectal neoplasms
Colorectal cancer metastatic
carbamates
sulfonamides

---
https://www.has-sante.fr/jcms/p_3152658/fr/vosevi
2020
false
false
false
France
sofosbuvir, velpatasvir and voxilaprevir
drug combinations
Sofosbuvir
velpatasvir
voxilaprevir
adult
administration, oral
treatment outcome
insurance, health, reimbursement
hepatitis C, chronic
antiviral agents
evaluation of the transparency committee
carbamates
Heterocyclic Compounds, 4 or More Rings
sulfonamides
macrocyclic compounds
sofosbuvir velpatasvir voxilaprevir drug combination

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_08_Aff%20Hemato_MAJ_200819.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
baricitinib
tofacitinib
Janus Kinase Inhibitors
risk factors
blood cell count
continuity of patient care
neutropenia
lymphopenia
anemia
algorithms
guideline
hematologic diseases
lymphoma
arthritis, rheumatoid
azetidines
sulfonamides
pyrimidines
pyrroles
piperidines

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_09_Digestif_Hepatiq_MAJ_220719.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
hepatic insufficiency
hepatitis B
hepatitis C
tofacitinib
baricitinib
Alanine aminotransferase outside reference range (finding)
transaminases
intestinal perforation
arthritis, rheumatoid
guideline
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_18_Spondyloarthrites_MAJ_220719.pdf
2019
false
false
false
France
adult
tofacitinib
tofacitinib
administration, oral
baricitinib
baricitinib
spondylitis, ankylosing
arthritis, psoriatic
guideline
Janus Kinase Inhibitors
spondylarthropathies
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
https://www.has-sante.fr/portail/jcms/c_2913082/fr/cosopt
2019
false
true
false
false
France
dorzolamide-timolol combination
drug combinations
sulfonamides
thiophenes
timolol
dorzolamide
antiglaucoma preparations
glaucoma
administration, ophthalmic
insurance, health, reimbursement
Intraocular pressure high
intraocular pressure
glaucoma, open-angle
exfoliation syndrome
sulfonamides
thiophenes
timolol
evaluation of the transparency committee
cosopt

---
https://www.ansm.sante.fr/actualites/venclyxto-venetoclax-signal-de-securite-issu-de-lessai-clinique-evaluant-le-venetoclax-dans-le-traitement-du-myelome-multiple
2019
false
false
false
France
French
pharmacovigilance note
clinical trials as topic
multiple myeloma
Infections
Infections
venetoclax
antineoplastic agents
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/jcms/p_3067182/fr/braftovi-mektovi
2019
false
true
false
false
France
French
antineoplastic combined chemotherapy protocols
encorafenib
binimetinib
administration, oral
protein kinase inhibitors
survival analysis
adult
insurance, health, reimbursement
melanoma
Unresectable Melanoma
BRAF V600 Mutation
proto-oncogene proteins b-raf
encorafenib
binimetinib
carbamates
sulfonamides

---
https://www.has-sante.fr/jcms/p_3103874/fr/votrient
2019
false
false
false
France
sarcoma
Soft Tissue Sarcoma
treatment outcome
survival analysis
pazopanib
protein kinase inhibitors
protein-tyrosine kinases
adult
pazopanib
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
pazopanib
pyrimidines
sulfonamides
pyrimidines
sulfonamides

---
https://www.has-sante.fr/jcms/p_3106167/fr/venclyxto
2019
false
false
false
France
French
evaluation of the transparency committee
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/jcms/p_3114485/fr/maviret
2019
false
false
false
France
glecaprevir and pibrentasvir
adult
adolescent
hepatitis C, chronic
glecaprevir
pibrentasvir
antiviral agents
insurance, health, reimbursement
treatment outcome
administration, oral
evaluation of the transparency committee
glecaprevir
quinoxalines
sulfonamides
benzimidazoles
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
https://www.has-sante.fr/jcms/p_3114479/fr/maviret
2019
false
false
false
France
French
insurance, health, reimbursement
treatment outcome
antiviral agents
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
glecaprevir
pibrentasvir
administration, oral
glecaprevir and pibrentasvir
hepatitis C, chronic
adult
adolescent
renal insufficiency, chronic
Duration of treatment (qualifier value)
glecaprevir
quinoxalines
sulfonamides
benzimidazoles
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-VEGFR-axitinib-cabozantinib-pazopanib-sorafenib-sunitinib
2019
false
false
false
France
Axitinib
cabozantinib
pazopanib
Sorafenib
Sunitinib
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
risk factors
patient education as topic
continuity of patient care
administration, oral
receptors, vascular endothelial growth factor
carcinoma, renal cell
drug interactions
pregnancy
Tyrosine Kinase Inhibitors
guidelines for drug use
Sorafenib
pazopanib
Axitinib
Sunitinib
cabozantinib
pyrimidines
sulfonamides
anilides
pyridines
pyrimidines
sulfonamides
anilides
pyridines
anilides
pyridines
pyrimidines
sulfonamides

---
https://www.has-sante.fr/jcms/p_3118709/fr/votrient
2019
false
false
false
France
pazopanib
adult
carcinoma, renal cell
sarcoma
Soft Tissue Sarcoma
protein kinase inhibitors
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
pazopanib
pyrimidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_06_%20Cardio_MAJ_220719.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
cardiovascular agents
anticoagulants
tofacitinib
baricitinib
cholesterol
Janus Kinase Inhibitors
risk
risk factors
drug interactions
guideline
arthritis, rheumatoid
cardiovascular diseases
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_07_Cancer_MAJ_220719.pdf
2019
false
false
false
France
neoplasms
risk
Janus Kinase Inhibitors
Janus Kinase Inhibitors
tofacitinib
baricitinib
guideline
arthritis, rheumatoid
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
https://www.anses.fr/fr/system/files/EAUX2017SA0063.pdf
2018
France
scientific and technical information
Health Care Category
humans
water consumption
maximal
Water
water
determinate
water
homo sapiens
Water
inlets
uterine artery embolization
dimethyl-diamine-sulfone
drinking
bays
dimethyl-diamine-sulfone
sulfonamides

---
https://www.ema.europa.eu/en/medicines/human/EPAR/braftovi
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
encorafenib
encorafenib
drug approval
europe
treatment outcome
melanoma
melanoma
BRAF V600 Mutation
proto-oncogene proteins b-raf
mutation
antineoplastic combined chemotherapy protocols
administration, oral
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
raf kinases
protein kinase inhibitors
protein kinase inhibitors
Progression-Free survival
survival analysis
drug evaluation, preclinical
colorectal neoplasms
neoplasm metastasis
metastatic colorectal cancer with a BRAF V600E mutation
Binimetinib/Encorafenib Regimen
Cetuximab/Encorafenib Regimen
encorafenib
carbamates
sulfonamides
disease-free survival
carbamates
sulfonamides
carbamates
sulfonamides

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00339
2018
false
false
false
Canada
French
English
drug information
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://ansm.sante.fr/informations-de-securite/zelboraf-cotellic-v-rappel-du-risque-datteintes-opthalmiques-et-de-leur-prise-en-charge
2018
false
false
false
France
French
pharmacovigilance note
retinal diseases
vision disorders
cobimetinib
continuity of patient care
mass screening
risk
guidelines for drug use
pharmacovigilance
uveitis
cobimetinib
indoles
sulfonamides
azetidines
piperidines
Vemurafenib

---
https://www.has-sante.fr/portail/jcms/c_2839017/fr/bosentan-ohre-pharma
2018
false
false
false
France
French
evaluation of the transparency committee
sulfonamides
Bosentan

---
http://conseil-scientifique.public.lu/fr/publications/oncologie/vemurafenib-mise-a-jour-2018.html
2018
false
false
true
Luxembourg
French
administration, oral
vemurafenib
guidelines for drug use
BRAF protein, human
protein kinase inhibitors
melanoma
neoplasm metastasis
Metastatic Melanoma
BRAF V600E Mutation Present
Unresectable Malignant Neoplasm
adult
antineoplastic combined chemotherapy protocols
Off-Label use
mutation
melanoma
indoles
sulfonamides
proto-oncogene proteins b-raf
Vemurafenib

---
http://www.cri-net.com/fiches-pratiques-et-recommandations/prise-en-charge-patients-JAKi
2018
false
false
false
France
continuity of patient care
pregnancy
vaccination
travel
virus diseases
bacterial infections
cardiovascular diseases
neoplasms
lymphoma
digestive system diseases
hematologic diseases
dental care
surgical procedures, operative
tofacitinib
baricitinib
drug therapy, combination
arthritis, rheumatoid
Contraindications, Drug
drug interactions
Evidence-Based medicine
baricitinib
tofacitinib
guidelines for drug use
case management
Janus Kinase Inhibitors
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.has-sante.fr/portail/jcms/c_2740916/fr/bosentan-accord
2017
false
false
false
France
French
evaluation of the transparency committee
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
drugs, generic
sulfonamides
Bosentan

---
https://www.has-sante.fr/portail/jcms/c_2818016/fr/maviret
https://www.has-sante.fr/portail/jcms/c_2818016/fr/maviret-glecaprevir-/pibrentasvir-association-fixe-d-antiviraux-a-action-directe
2017
false
false
false
false
French
treatment outcome
drug combinations
antiviral agents
antiviral agents
administration, oral
hepatitis C, chronic
adult
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)
Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)
glecaprevir and pibrentasvir
evaluation of the transparency committee
insurance, health, reimbursement
glecaprevir
glecaprevir
benzimidazoles
benzimidazoles
guidelines for drug use
pibrentasvir
pibrentasvir
glecaprevir
glecaprevir
quinoxalines
sulfonamides
quinoxalines
sulfonamides
glecaprevir and pibrentasvir
pyrrolidines

---
https://www.has-sante.fr/portail/jcms/c_2817995/fr/vosevi
2017
false
false
false
France
French
sulfonamides
sulfonamides
macrocyclic compounds
macrocyclic compounds
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
treatment outcome
administration, oral
hepatitis C, chronic
antiviral agents
antiviral agents
adult
NS-5 protein, hepatitis C virus
NS-5a protein, hepatitis C virus
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
viral nonstructural proteins
serine proteases
insurance, health, reimbursement
evaluation of the transparency committee
sofosbuvir, velpatasvir and voxilaprevir
voxilaprevir
voxilaprevir
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations
sofosbuvir velpatasvir voxilaprevir drug combination

---
https://www.has-sante.fr/portail/jcms/c_2814693/fr/bosentan-zentiva
2017
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
sulfonamides
Bosentan

---
https://www.ema.europa.eu/medicines/human/EPAR/Vosevi
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
sulfonamides
sulfonamides
macrocyclic compounds
macrocyclic compounds
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
drug approval
europe
treatment outcome
product surveillance, postmarketing
administration, oral
hepatitis C, chronic
antiviral agents
antiviral agents
adult
drug interactions
pregnancy
breast feeding
NS-5 protein, hepatitis C virus
NS-5a protein, hepatitis C virus
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
viral nonstructural proteins
serine proteases
drug evaluation, preclinical
sofosbuvir, velpatasvir and voxilaprevir
voxilaprevir
voxilaprevir
NS3-4A serine protease, Hepatitis C virus
Sofosbuvir
velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations
sofosbuvir velpatasvir voxilaprevir drug combination

---
https://www.has-sante.fr/portail/jcms/c_2778111/fr/olumiant
https://www.has-sante.fr/portail/jcms/c_2778111/fr/olumiant-baricitinib-anti-jak-1et-2
2017
false
false
false
France
French
baricitinib
treatment outcome
drug therapy, combination
arthritis, rheumatoid
administration, oral
adult
aged
immunosuppressive agents
janus kinase 2
janus kinase 1
evaluation of the transparency committee
methotrexate
guidelines for drug use
Tyrosine Kinase Inhibitors
baricitinib
azetidines
sulfonamides

---
Maviret - glecaprevir / pibrentasvir
https://www.ema.europa.eu/medicines/human/EPAR/Maviret
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
treatment outcome
product surveillance, postmarketing
drug combinations
antiviral agents
antiviral agents
tablets
administration, oral
hepatitis C, chronic
adult
drug interactions
pregnancy
breast feeding
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)
Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action (substance)
drug evaluation, preclinical
glecaprevir and pibrentasvir
benzimidazoles
benzimidazoles
glecaprevir
glecaprevir
pibrentasvir
pibrentasvir
glecaprevir
glecaprevir
quinoxalines
sulfonamides
quinoxalines
sulfonamides
glecaprevir and pibrentasvir
pyrrolidines

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds

---
https://www.has-sante.fr/portail/jcms/c_2788624/fr/venclyxto
https://www.has-sante.fr/portail/jcms/c_2788624/fr/venclyxto-venetoclax-inhibiteur-de-bcl-2
2017
false
false
false
France
French
treatment outcome
orphan drug production
leukemia, lymphocytic, chronic, B-Cell
administration, oral
B-Cell leukemia 2 family proteins
antineoplastic agents
antineoplastic agents
leukemia, lymphocytic, chronic, B-Cell
Loss of Chromosome 17p
genes, p53
mutation
adult
aged
venetoclax
evaluation of the transparency committee
venetoclax
venetoclax
Proto-Oncogene proteins c-bcl-2
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/portail/jcms/c_2788630/fr/bosentan-sandoz
2017
false
false
false
France
French
evaluation of the transparency committee
sulfonamides
Bosentan

---
https://www.has-sante.fr/portail/jcms/c_2775799/fr/viekirax-exviera
2017
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
administration, oral
hepatitis C, chronic
drug therapy, combination
adult
anilides
carbamates
antiviral agents
macrocyclic compounds
ritonavir
sulfonamides
uracil
treatment outcome
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
ombitasvir
dasabuvir
paritaprevir
dasabuvir
ombitasvir, paritaprevir and ritonavir
ombitasvir
dasabuvir
paritaprevir

---
https://www.has-sante.fr/portail/jcms/c_2773803/fr/bosentan-mylan
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
bosentan
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
sulfonamides
Bosentan

---
https://www.has-sante.fr/portail/jcms/c_2773809/fr/bosentan-biogaran
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
bosentan
sulfonamides
Bosentan

---
https://www.has-sante.fr/portail/jcms/c_2773800/fr/bosentan-teva
2017
false
false
false
France
French
evaluation of the transparency committee
sulfonamides
Bosentan

---
http://www.has-sante.fr/portail/jcms/c_2755482/fr/zelboraf
2017
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
indoles
sulfonamides
Vemurafenib

---
https://www.ema.europa.eu/medicines/human/EPAR/Olumiant
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
baricitinib
drug approval
europe
baricitinib
treatment outcome
drug therapy, combination
arthritis, rheumatoid
administration, oral
adult
aged
immunosuppressive agents
immunosuppressive agents
pregnancy
breast feeding
product surveillance, postmarketing
drug interactions
janus kinase 2
janus kinase 1
drug evaluation, preclinical
Tyrosine Kinase Inhibitors
baricitinib
azetidines
sulfonamides
azetidines
sulfonamides

---
http://www.has-sante.fr/portail/jcms/c_2747505/fr/bosentan-arrow
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
hypertension, pulmonary
sulfonamides
Bosentan

---
http://www.has-sante.fr/portail/jcms/c_2740904/fr/bosentan-mylan
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
sulfonamides
Bosentan

---
http://www.has-sante.fr/portail/jcms/c_2740907/fr/bosentan-teva
2017
false
false
false
France
French
evaluation of the transparency committee
Bosentan monohydrate 62.5mg tablet (product)
Bosentan monohydrate 125mg tablet (product)
drugs, generic
sulfonamides
Bosentan

---
http://www.has-sante.fr/portail/jcms/c_2589172/fr/azarga
2016
true
France
French
adult
azarga
adrenergic beta-antagonists
timolol
brinzolamide
glaucoma, open-angle
drug combinations
ocular hypertension
sulfonamides
thiazines
carbonic anhydrase inhibitors
timolol, combinations
timolol maleate
administration, ophthalmic
evaluation of the transparency committee
sulfonamides
thiazines
timolol

---
https://minerva-ebp.be/FR/Analysis/432
2016
false
false
false
Belgium
French
french abstract
scientific and technical information
treatment outcome
ureterolithiasis
nifedipine
sulfonamides
Tamsulosin

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BRAF-en-monotherapie-vemurafenib-dabrafenib-Medicaments-ciblant-BRAF-ou-MEK-en-association-vemurafenib-cobimetinib-dabrafenib-trametinib
2016
false
false
false
France
French
guidelines for drug use
practice guideline
patients guideline
protein kinase inhibitors
protein kinase inhibitors
Drug-Related side effects and adverse reactions
administration, oral
drug interactions
vemurafenib
vemurafenib
antineoplastic combined chemotherapy protocols
vemurafenib
dabrafenib
dabrafenib
dabrafenib
BRAF protein, human
Metastatic Melanoma
melanoma
melanoma
neoplasm metastasis
BRAF Gene Mutation
continuity of patient care
drug monitoring
interdisciplinary communication
protein kinase inhibitors
vemurafenib
dabrafenib
pregnancy
imidazoles
oximes
imidazoles
oximes
proto-oncogene proteins b-raf
imidazoles
oximes
indoles
sulfonamides
indoles
sulfonamides
indoles
sulfonamides
Vemurafenib
Vemurafenib
Vemurafenib

---
http://www.has-sante.fr/portail/jcms/c_2741821/fr/combodart
http://www.has-sante.fr/portail/jcms/c_2741821/fr/combodart-dutasteride-tamsulosine-inhibiteur-de-la-5-reductase-alpha-bloquant
2016
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
drug combinations
administration, oral
adrenergic alpha-1 receptor antagonists
adrenergic alpha-1 receptor antagonists
5-alpha reductase inhibitors
5-alpha reductase inhibitors
Dutasteride
Dutasteride
tamsulosin and dutasteride
prostatic hyperplasia
tamsulosin hydrochloride
tamsulosin hydrochloride
treatment outcome
insurance, health, reimbursement
urinary retention
prostatic hypertrophy, benign
urological agents
urological agents
sulfonamides
sulfonamides
Tamsulosin
Tamsulosin

---
SUNVEPRA - Summary Basis of Decision (SBD)
Asunaprevir, 100 mg , capsule, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00297
2016
false
false
false
false
Canada
French
English
summary of product characteristics
administration, oral
asunaprevir
asunaprevir
NS3 protein, hepatitis C virus
risk assessment
drug evaluation
drug approval
canada
adult
hepatitis C, chronic
drug therapy, combination
Hepatitis C virus genotype 4 (organism)
Hepatitis C virus genotype 1 (organism)
Cirrhosis of liver due to chronic hepatitis C (disorder)
antiviral agents
antiviral agents
protease inhibitors
protease inhibitors
treatment outcome
asunaprevir
isoquinolines
sulfonamides
isoquinolines
sulfonamides
viral nonstructural proteins

---
https://ansm.sante.fr/tableau-atu-rtu/venetoclax-abbvie-10-mg-50-mg-et-100-mg-comprimes-pellicules
2016
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
adult
leukemia, lymphocytic, chronic, B-Cell
chromosome 17 deletion
mutation
TP53 Gene
venetoclax
administration, oral
antineoplastic agents
drug evaluation, preclinical
treatment outcome
Proto-Oncogene proteins c-bcl-2
venetoclax
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
Smith-Magenis syndrome
chromosome deletion
chromosomes, human, pair 17

---
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-05-fra.php#mise_%C3%A0_jour
2016
false
false
false
Canada
French
pharmacovigilance note
socioeconomic factors
monograph
cirrhosis of liver, nos
patients
has patient
sectional
indicators
decompensation
administration of medication, nos
effective
drug interactions
disease of liver, nos
observation
drug monitoring
pharmacovigilance
dasabuvir
contraindication to
liver cirrhosis
risk
effect modifier, epidemiologic
drug interaction
hepatic failure, nos
positive
administration
hepatic insufficiency
medication adherence
cirrhosis
monograph
indicators and reagents
observation
drug monitoring
dasabuvir
organization and administration
fibrosis
sulfonamides
uracil

---
http://www.has-sante.fr/portail/jcms/c_2633680/fr/antiviraux-d-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
adult
hepatitis C, chronic
drug therapy, combination
Sofosbuvir
antiviral agents
direct acting antivirals
daclatasvir
Simeprevir
ledipasvir, sofosbuvir drug combination
dasabuvir
drug combinations
ombitasvir
ritonavir
paritaprevir
fibrosis, liver
risk
has patient
hepacivirus
Infections
autoimmune diseases
hepatic fibrosis, nos
fibrosis
hepatitis C virus
human enterovirus 72
hepatitis C, chronic
business
liver cirrhosis
socialism
patients
chronic infectious disease
guideline
antiviral agents
chronic hepatitis, nos
health
case management
hepatitis c virus
hepatitis a virus
dasabuvir
ombitasvir
paritaprevir
daclatasvir
fibrosis
commerce
patients
guideline
benzimidazoles
fluorenes
uridine monophosphate
sulfonamides
uracil
uracil
anilides
carbamates
macrocyclic compounds
imidazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Venclyxto
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
venetoclax
venetoclax
leukemia, lymphocytic, chronic, B-Cell
drug approval
europe
risk assessment
pregnancy
breast feeding
drug interactions
administration, oral
B-Cell leukemia 2 family proteins
antineoplastic agents
antineoplastic agents
leukemia, lymphocytic, chronic, B-Cell
Loss of Chromosome 17p
genes, p53
product surveillance, postmarketing
mutation
continuity of patient care
drug monitoring
adult
aged
drug evaluation, preclinical
Response Rate
venetoclax
venetoclax
venetoclax
Proto-Oncogene proteins c-bcl-2
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-12-fra.php#zelb
2016
false
false
false
Canada
French
English
drug evaluation
risk assessment
vemurafenib
vemurafenib
melanoma
neoplasm metastasis
protein kinase inhibitors
anemia, aplastic
bone marrow
aplastic anemia secondary to chemicals
product surveillance, postmarketing
indoles
sulfonamides
Vemurafenib

---
http://www.has-sante.fr/portail/jcms/c_2728866/fr/reevaluation-des-antiviraux-d-action-directe-dans-le-traitement-de-l-hepatite-c
2016
false
false
false
France
French
guidelines for drug use
practice guideline
antiviral agents
hepatitis C, chronic
drug evaluation
Sofosbuvir
administration, oral
Simeprevir
direct acting antivirals
daclatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
drug therapy, combination
ritonavir
ombitasvir
paritaprevir
dasabuvir
drug resistance, viral
drug interactions
treatment outcome
daclatasvir
ombitasvir
paritaprevir
dasabuvir
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
anilides
carbamates
macrocyclic compounds
sulfonamides
uracil
uracil

---
http://www.has-sante.fr/portail/jcms/c_2621282/fr/prezista
2016
false
France
French
Darunavir
Darunavir
human immunodeficiency virus i infection
ritonavir
evaluation of the transparency committee
administration, oral
darunavir ethanolate
drug therapy, combination
HIV-1
hiv infections
hiv protease inhibitors
hiv protease inhibitors
adult
child
adolescent
treatment outcome
clinical trials, phase ii as topic
insurance, health, reimbursement
sulfonamides
sulfonamides
darunavir ethanolate

---
https://www.ema.europa.eu/medicines/human/EPAR/Exviera
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
sulfonamides
sulfonamides
antiviral agents
antiviral agents
drug approval
europe
uracil
adult
hepatitis C, chronic
drug therapy, combination
administration, oral
enzyme inhibitors
enzyme inhibitors
NS-5b protein, hepatitis C virus
NS-5 protein, hepatitis C virus
drug monitoring
product surveillance, postmarketing
risk management
drug interactions
pregnancy
breast feeding
drug resistance, viral
clinical trials as topic
drug evaluation, preclinical
dasabuvir
dasabuvir
dasabuvir
viral nonstructural proteins
dasabuvir
dasabuvir

---
Skin-cancer drug Zelboraf (vemurafenib): new warning on the risk of pancreatitis
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/43697a-fra.php
2015
false
false
false
Canada
French
English
pancreatitis
pharmacovigilance note
vemurafenib
vemurafenib
melanoma
protein kinase inhibitors
vemurafenib
adult
protein kinase inhibitors
Drug-induced acute pancreatitis (disorder)
indoles
sulfonamides
indoles
sulfonamides
Vemurafenib
Vemurafenib

---
http://www.has-sante.fr/portail/jcms/c_2025737/fr/exviera/viekirax
http://www.has-sante.fr/portail/jcms/c_2025737/fr/viekirax-ombitasvir/paritaprevir/ritonavir-association-fixe-dantiviraux-a-action-directe-exviera-dasabuvir-antiviral-a-action-directe
2015
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
drug combinations
administration, oral
hepatitis C, chronic
drug therapy, combination
adult
anilides
anilides
carbamates
carbamates
antiviral agents
antiviral agents
macrocyclic compounds
macrocyclic compounds
ritonavir
ritonavir
sulfonamides
sulfonamides
uracil
treatment outcome
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
Hepatitis C virus genotype 4 (organism)
ombitasvir
paritaprevir
dasabuvir
paritaprevir
dasabuvir
ombitasvir, paritaprevir and ritonavir
ombitasvir
dasabuvir

---
http://www.has-sante.fr/portail/jcms/c_2031539/fr/dualkopt
2015
false
false
false
France
French
evaluation of the transparency committee
timolol, combinations
dorzolamide hydrochloride-timolol maleate combination
dorzolamide hydrochloride-timolol maleate combination
dorzolamide-timolol combination
dorzolamide-timolol combination
dorzolamide
dorzolamide
ophthalmic solutions
administration, ophthalmic
adrenergic beta-antagonists
adrenergic beta-antagonists
carbonic anhydrase inhibitors
carbonic anhydrase inhibitors
treatment outcome
insurance, health, reimbursement
ocular hypertension
exfoliation syndrome
glaucoma, open-angle
drug combinations
sulfonamides
thiophenes
timolol
drug combinations
sulfonamides
thiophenes
timolol

---
http://www.has-sante.fr/portail/jcms/c_2052620/fr/eurelix
2015
false
false
France
French
evaluation of the transparency committee
piretanide
sulfonamides

---
Information Update - Risk of Serious Liver Injury associated with Hepatitis C Treatments: Holkira Pak and Technivie
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/55800a-fra.php
2015
false
false
false
Canada
French
English
Chemical and Drug Induced Liver Injury
pharmacovigilance note
antiviral agents
hepatitis C, chronic
drug combinations
antiviral agents
ombitasvir
paritaprevir
ritonavir
dasabuvir
ombitasvir
dasabuvir
anilides
carbamates
sulfonamides
uracil
uracil
macrocyclic compounds
Contraindications, Drug

---
ZELBORAF (vemurafenib) - Risk of Radiation Sensitization or Radiation Recall Reaction
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/56368a-fra.php
2015
false
false
false
Canada
French
English
pharmacovigilance note
radiation injuries
melanoma
melanoma
vemurafenib
vemurafenib
radiotherapy
adult
BRAF V600E Mutation Present
chemoradiotherapy
indoles
sulfonamides
Vemurafenib

---
http://www.has-sante.fr/portail/jcms/c_2583127/fr/opsumit
http://www.has-sante.fr/portail/jcms/c_2583127/fr/opsumit-macitentan-antagonistes-des-recepteurs-de-l-endotheline
2015
false
false
false
France
French
evaluation of the transparency committee
macitentan
hypertension, pulmonary
adult
administration, oral
macitentan
treatment outcome
drug therapy, combination
idiopathic pulmonary arterial hypertension
Pulmonary arterial hypertension associated with connective tissue disease
Pulmonary arterial hypertension associated with congenital heart disease
orphan drug production
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Familial Primary Pulmonary Hypertension
guidelines for drug use
Product containing macitentan in oral dose form (medicinal product form)
pyrimidines
sulfonamides

---
http://www.has-sante.fr/portail/jcms/c_2005033/fr/simbrinza
http://www.has-sante.fr/portail/jcms/c_2005033/fr/simbrinza-brinzolamide-brimonidine-anti-glaucomateux
2014
false
false
false
France
French
evaluation of the transparency committee
glaucoma, open-angle
ocular hypertension
drug combinations
ophthalmic solutions
administration, ophthalmic
adult
treatment outcome
insurance, health, reimbursement
brinzolamide
brinzolamide, combinations
carbonic anhydrase inhibitors
adrenergic alpha-2 receptor agonists
guidelines for drug use
Brimonidine Tartrate
sulfonamides
thiazines

---
http://www.has-sante.fr/portail/jcms/c_1769783/fr/opsumit
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
macitentan
macitentan
hypertension, pulmonary
adult
administration, oral
macitentan
treatment outcome
drug therapy, combination
idiopathic pulmonary arterial hypertension
Pulmonary arterial hypertension associated with connective tissue disease
Pulmonary arterial hypertension associated with congenital heart disease
orphan drug production
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Familial Primary Pulmonary Hypertension
Product containing macitentan in oral dose form (medicinal product form)
pyrimidines
sulfonamides
pyrimidines
sulfonamides

---
https://www.ema.europa.eu/medicines/human/EPAR/Simbrinza
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
drug combinations
ophthalmic solutions
administration, ophthalmic
brinzolamide
brinzolamide
adult
glaucoma, open-angle
ocular hypertension
aged
drug interactions
pregnancy
breast feeding
carbonic anhydrase inhibitors
carbonic anhydrase inhibitors
adrenergic alpha-2 receptor agonists
adrenergic alpha-2 receptor agonists
intraocular pressure
clinical trials as topic
drug evaluation, preclinical
brinzolamide, combinations
Brimonidine Tartrate
Brimonidine Tartrate
sulfonamides
thiazines
sulfonamides
thiazines

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=64146217
2014
false
false
false
France
French
summary of product characteristics
simeprevir
simeprevir
capsules
heterocyclic compounds, 3-ring
sulfonamides

---
http://www.meddispar.fr/Medicaments/VOTRIENT-200-B-30/(type)/letter/(value)/V/(cip)/3400949131341
2014
false
false
false
drug information
administration, oral
drug prescriptions
legislation, drug
pazopanib
pazopanib
continuity of patient care
pyrimidines
sulfonamides

---
http://www.meddispar.fr/Medicaments/VOTRIENT-400-B-30/(type)/letter/(value)/V/(cip)/3400949131570
http://www.meddispar.fr/Medicaments/VOTRIENT-400-B-60/%28type%29/letter/%28value%29/V/%28cip%29/3400949131631
2014
false
false
false
drug information
administration, oral
drug prescriptions
legislation, drug
continuity of patient care
pazopanib
pazopanib
pyrimidines
sulfonamides

---
https://www.ema.europa.eu/medicines/human/EPAR/Opsumit
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
macitentan
macitentan
macitentan
orphan drug production
hypertension, pulmonary
adult
administration, oral
product surveillance, postmarketing
continuity of patient care
drug monitoring
aged
drug interactions
pregnancy
breast feeding
fertility
contraception
reproduction
clinical trials, phase iii as topic
drug evaluation, preclinical
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Product containing macitentan in oral dose form (medicinal product form)
pyrimidines
sulfonamides
pyrimidines
sulfonamides

---
http://www.lecrat.eu/?s=Nim%C3%A9sulide
2013
France
French
pregnancy
sulfonamides
anti-inflammatory agents, non-steroidal
nimesulide
nimesulide
sulfonamides
drug information

---
http://www.lecrat.eu/?s=Dorzolamide
2013
false
France
French
administration, ophthalmic
pregnancy
breast feeding
sulfonamides
thiophenes
antihypertensive agents
carbonic anhydrase inhibitors
dorzolamide
dorzolamide
dorzolamide hydrochloride
drug information

---
http://www.lecrat.eu/?s=Brinzolamide
2013
false
France
French
administration, ophthalmic
pregnancy
breast feeding
sulfonamides
thiazines
carbonic anhydrase inhibitors
brinzolamide
brinzolamide
drug information

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/904
2013
false
France
French
Stage IV Cutaneous Melanoma AJCC v6 and v7
melanoma, cutaneous malignant
melanoma
neoplasm metastasis
skin neoplasms
journal article
antineoplastic agents
antineoplastic agents
antibodies, monoclonal
indoles
sulfonamides
melanoma
Vemurafenib
Vemurafenib

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00164
2012
false
false
false
Canada
vemurafenib
Product containing vemurafenib (medicinal product)
drug information
indoles
sulfonamides
Vemurafenib

---
http://www.has-sante.fr/portail/jcms/c_1355322/zelboraf-vemurafenib-inhibiteur-de-la-proteine-kinase-braf
http://www.has-sante.fr/portail/jcms/c_1355321/zelboraf-synthese-ct12121
2012
France
French
melanoma
evaluation of the transparency committee
guidelines for drug use
vemurafenib
indoles
sulfonamides
proto-oncogene proteins b-raf
Vemurafenib

---
http://www.oncoprof.net/Generale2000/g11_AutresTraitements/g11_at10e.php
2011
false
true
false
France
receptors, vascular endothelial growth factor
pyrimidines
pyrimidines
pyrimidines
pyrimidines
sulfonamides
sulfonamides
sulfonamides
sulfonamides
Tyrosine Kinase Inhibitors
pazopanib

---
https://www.ema.europa.eu/medicines/human/EPAR/Telzir
2011
United Kingdom
French
English
syndication feed
Contraindications, Procedure
hiv infections
acquired immunodeficiency syndrome
organophosphates
carbamates
anti-hiv agents
adult
HIV-1
drug therapy, combination
hiv protease inhibitors
drug evaluation
treatment outcome
organophosphates
organophosphates
carbamates
carbamates
drug interactions
anti-hiv agents
anti-hiv agents
hiv protease inhibitors
hiv protease inhibitors
sulfonamides
sulfonamides
sulfonamides
sulfonamides
tablets
pharmaceutical solutions
administration, oral
organophosphates
carbamates
anti-hiv agents
hiv protease inhibitors
child
adolescent
anti-hiv agents
anti-hiv agents
hiv protease inhibitors
hiv protease inhibitors
organophosphates
organophosphates
carbamates
carbamates
sulfonamides
sulfonamides
pregnancy
breast feeding
drug evaluation, preclinical
sulfonamides
organophosphates
carbamates
anti-hiv agents
hiv protease inhibitors
drug labeling
drug approval
fosamprenavir
fosamprenavir
carbamates
organophosphates
sulfonamides
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug

---
https://www.ema.europa.eu/medicines/human/EPAR/Azopt
2011
United Kingdom
English
French
syndication feed
Contraindications, Procedure
brinzolamide
thiazines
carbonic anhydrase inhibitors
ocular hypertension
sulfonamides
thiazines
carbonic anhydrase inhibitors
treatment outcome
drug evaluation
drug therapy, combination
glaucoma, open-angle
ophthalmic solutions
sulfonamides
thiazines
carbonic anhydrase inhibitors
adult
aged
child
adolescent
carbonic anhydrase inhibitors
sulfonamides
thiazines
drug interactions
pregnancy
breast feeding
carbonic anhydrase inhibitors
carbonic anhydrase inhibitors
thiazines
thiazines
sulfonamides
sulfonamides
sulfonamides
drug evaluation, preclinical
thiazines
sulfonamides
carbonic anhydrase inhibitors
drug labeling
drug approval
brinzolamide
administration, ophthalmic
sulfonamides
thiazines
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug

---
https://www.ema.europa.eu/medicines/human/EPAR/Agenerase
2011
false
United Kingdom
English
French
syndication feed
Contraindications, Procedure
sulfonamides
sulfonamides
sulfonamides
anti-hiv agents
anti-hiv agents
anti-hiv agents
anti-hiv agents
anti-hiv agents
anti-hiv agents
hiv protease inhibitors
hiv protease inhibitors
hiv protease inhibitors
hiv protease inhibitors
hiv protease inhibitors
hiv protease inhibitors
amprenavir
child
anti-hiv agents
hiv infections
HIV-1
hiv protease inhibitors
treatment outcome
drug evaluation
pregnancy
breast feeding
drug labeling
drug approval
drug evaluation, preclinical
administration, oral
sulfonamides
capsules
carbamates
adult
carbamates
carbamates
carbamates
carbamates
drug interactions
carbamates
drug resistance, viral
carbamates
sulfonamides
sulfonamides
sulfonamides
amprenavir
carbamates
sulfonamides
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62715965
2010
France
French
capsules
administration, oral
piretanide
piretanide
piretanide
tablets, enteric-coated
hypertension
sulfonamides
sulfonamides
diuretics
diuretics
drug interactions
pregnancy
breast feeding
sulfonamides
summary of product characteristics
package leaflet

---
http://www.meddispar.fr/medicaments/3640639
2008
France
French
fosamprenavir
organophosphates
sulfonamides
drug prescriptions
legislation, drug
carbamates
tablets
administration, oral
fosamprenavir
drug information

---
https://minerva-ebp.be/fr/article/583
2007
false
minerva-ebm.be
Belgium
French
omeprazole
anti-inflammatory agents, non-steroidal
pyrazoles
sulfonamides
anti-ulcer agents
peptic ulcer hemorrhage
proton pump inhibitors
peptic ulcer hemorrhage
cyclooxygenase inhibitors
critical appraisal or critical reading

---
https://ansm.sante.fr/uploads/2021/03/11/a3285fe42fb091c553160cae4a578bd0.pdf
2005
false
France
French
Contraindications, Procedure
risk assessment
anti-inflammatory agents, non-steroidal
sulfonamides
drug tolerance
lactones
sulfonamides
lactones
france
treatment outcome
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
rheumatology
drug evaluation
drug utilization review
lactones
cyclooxygenase inhibitors
sulfonamides
drug interactions
popular works
practice guideline
evaluation studies
Contraindications, Drug

---
http://www.has-sante.fr/portail/display.jsp?id=c_399918
2003
France
French
sulfonamides
cyclooxygenase inhibitors
arthritis, rheumatoid
osteoarthritis
dysmenorrhea
isoxazoles
valdecoxib
isoxazoles
sulfonamides
evaluation of the transparency committee

---
https://www.cadth.ca/sites/default/files/pdf/108_No33_valdecoxib_edrug_f.pdf
2002
Canada
French
sulfonamides
isoxazoles
adult
arthritis
dysmenorrhea
clinical trials as topic
anti-inflammatory agents, non-steroidal
cyclooxygenase inhibitors
valdecoxib
drug evaluation

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.